US BioTec Inc
US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. Its product portfolio consists of approximately 30 products, which stimulate plants that produce crops; correct microbial and mineral problems present in soils; and rehabilitate the soil ecosystem by breaking down the residual build-u… Read more
US BioTec Inc (USBC) - Net Assets
Latest net assets as of March 2005: $351.38K USD
Based on the latest financial reports, US BioTec Inc (USBC) has net assets worth $351.38K USD as of March 2005.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($939.54K) and total liabilities ($588.16K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $351.38K |
| % of Total Assets | 37.4% |
| Annual Growth Rate | 101.59% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 185.59 |
US BioTec Inc - Net Assets Trend (2003–2005)
This chart illustrates how US BioTec Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for US BioTec Inc (2003–2005)
The table below shows the annual net assets of US BioTec Inc from 2003 to 2005.
| Year | Net Assets | Change |
|---|---|---|
| 2005-12-31 | $172.91K | -11.51% |
| 2004-12-31 | $195.40K | +359.67% |
| 2003-12-31 | $42.51K | -- |
Equity Component Analysis
This analysis shows how different components contribute to US BioTec Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1204.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2005)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $642.39K | 371.51% |
| Total Equity | $172.91K | 100.00% |
US BioTec Inc Competitors by Market Cap
The table below lists competitors of US BioTec Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Compliance Energy Corporation
OTCGREY:CPYCF
|
$0.96 |
|
Ormet Corporation
PINK:ORMTQ
|
$0.96 |
|
Consolidated Eco-Systems Inc
PINK:EXSO
|
$0.96 |
|
Critical Solutions
PINK:CSLI
|
$0.96 |
|
China BCT Pharmacy Group Inc
PINK:CNBI
|
$0.96 |
|
Piksel Inc
PINK:PIKL
|
$0.96 |
|
New Frontier Energy Inc
PINK:NFEI
|
$0.96 |
|
Rainforest Resources Inc
OTCQB:RRIF
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in US BioTec Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2004 to 2005, total equity changed from 195,402 to 172,915, a change of -22,487 (-11.5%).
- Net loss of 376,315 reduced equity.
- Other factors increased equity by 353,828.
Equity Change Factors (2004 to 2005)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-376.31K | -217.63% |
| Other Changes | $353.83K | +204.63% |
| Total Change | $- | -11.51% |
Book Value vs Market Value Analysis
This analysis compares US BioTec Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $0.00 | $0.00 | x |
| 2004-12-31 | $0.00 | $0.00 | x |
| 2005-12-31 | $0.42 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently US BioTec Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -217.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.01%
- • Asset Turnover: 1.83x
- • Equity Multiplier: 5.17x
- Recent ROE (-217.63%) is below the historical average (-149.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -182.63% | -5.66% | 1.88x | 17.13x | $-81.88K |
| 2004 | -47.68% | -7.29% | 1.52x | 4.30x | $-112.70K |
| 2005 | -217.63% | -23.01% | 1.83x | 5.17x | $-393.61K |
Industry Comparison
This section compares US BioTec Inc's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $1,234,454,915
- Average return on equity (ROE) among peers: -88.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| US BioTec Inc (USBC) | $351.38K | -182.63% | 1.67x | $0.96 |
| Argo Living Soils Corp (ARLSF) | $117.11K | -241.15% | 0.57x | $4.77 Million |
| American Vanguard Corporation (AVD) | $282.36 Million | 4.53% | 0.52x | $93.02 Million |
| Bee Vectoring Technologies International Inc (BEVVF) | $1.82 Million | -170.52% | 0.16x | $47.51K |
| Benson Hill, Inc. Common Stock (BHIL) | $86.04 Million | -134.02% | 2.19x | $178.85K |
| BHILW (BHILW) | $86.04 Million | -134.02% | 2.19x | $286.16K |
| Bioceres Crop Solutions Corp (BIOX) | $351.38 Million | 0.92% | 1.43x | $16.37 Million |
| CO2 Gro Inc (BLONF) | $577.93K | -224.34% | 1.65x | $154.65K |
| China BlueChemical Ltd (CBLUF) | $7.05 Billion | 23.77% | 0.29x | $484.41 Million |
| CF Industries Holdings Inc (CF) | $4.39 Billion | 15.96% | 1.90x | $15.33 Billion |
| China Green Agriculture Inc (CGA) | $100.10 Million | -28.38% | 0.63x | $14.93 Million |